ROIV
Roivant Sciences Ltd.
Stock
$35.72+0.22 (+0.62%)Close Oct 2, 2026
Balance sheet
| Line | Q1 FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $3.8B | $4.3B | $4.9B | $6.5B | $1.7B | $2.1B | $2.1B |
| Inventory | — | — | — | $35M | $2.8M | $0 | — |
| Current assets | $4.7B | $5.2B | $5.0B | $6.7B | $1.8B | $2.1B | $2.2B |
| Intangible assets | — | — | — | $138M | $145M | $0 | — |
| Total assets | $5.3B | $5.7B | $5.4B | $7.2B | $2.4B | $2.6B | $2.6B |
| Current liabilities | $284M | $281M | $149M | $267M | $272M | $184M | $219M |
| Long-term debt | — | — | — | $419M | $335M | $210M | $170M |
| Total liabilities | $385M | $416M | $250M | $774M | $782M | $524M | $528M |
| Shareholders' equity | $4.2B | $4.5B | $4.7B | $6.0B | $1.2B | $1.7B | $1.8B |
| Shares outstanding | 722.3M | 719.3M | 679.8M | 738.7M | 766.8M | 700.8M | — |
| Current ratio | 16.72 | 18.37 | 33.47 | 25.24 | 6.60 | 11.64 | 9.99 |